DCM
TMO icon

DGS Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

DGS Capital Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$368K Buy
749
+90
+14% +$48.8K 0.06% 331
2025
Q4 		$382K Buy
659
+38
+6% +$21.5K 0.07% 260
2025
Q3 		$301K Buy
+621
New +$289K 0.05% 285
2022
Q1 		– Sell
-325
Closed -$217K – 215
2021
Q4 		$217K Buy
+325
New +$203K 0.14% 143

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

DGS Capital Management's TMO Position: Q1 2026 in Review

DGS Capital Management increased its Thermo Fisher Scientific (TMO) stake by 14% in Q1 2026, buying an estimated $48.8K and bringing the position to 749 shares worth $368K. The position accounts for 0.06% of the portfolio, ranked #331.

DGS Capital Management first reported a position in TMO in Q4 2021 and has held it in 4 quarters since. The position peaked at $382K in Q4 2025. 2,600 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • DGS Capital Management held 749 shares of Thermo Fisher Scientific worth $368K as of Q1 2026.
  • DGS Capital Management bought 90 Thermo Fisher Scientific shares in Q1 2026, an estimated $48.8K.
  • Thermo Fisher Scientific made up 0.06% of DGS Capital Management's portfolio in Q1 2026, its #331 holding.
  • DGS Capital Management first reported a position in Thermo Fisher Scientific in Q4 2021 and has held it in 4 quarters since.
  • DGS Capital Management's Thermo Fisher Scientific position peaked at $382K in Q4 2025.
  • 2,600 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on DGS Capital Management's 13F filing for Q1 2026, filed 28 Apr 2026.